CREEK & RIVER (4763) Q4 2026 earnings summary

Executive summary

• Achieved record-high sales and net income, surpassing initial plans even when excluding the impact of the Takahashi Shoten Group acquisition.

• Net sales rose 22.1% year-over-year to ¥61,393 million, with operating profit up 36.0% and profit attributable to owners of parent up 81.0%.

• Growth was broad-based, with six out of eight business categories increasing both revenue and profit year-over-year.

• Major segment growth was driven by the Creative field (Japan), CRES field, and Medical field.

• Significant positive impact from reduced tax expenses at Takahashi Shoten Group and a government subsidy for the Connect Around agritech business.

Financial highlights

• Sales: ¥61,393 million, up 22% year-over-year; operating profit: ¥4,914 million, up 36% year-over-year; net income attributable to parent company shareholders: ¥4,075 million, up 81% year-over-year.

• Gross profit margin: 36.4% (down 0.5pt YoY); operating profit margin: 8.0% (up 0.8pt YoY); gross profit increased to ¥22,326 million.

• Basic earnings per share rose to ¥192.61 from ¥105.45 year-over-year.

• Cash & deposits increased by ¥4,889 million, mainly due to consolidation of Takahashi Shoten Group; cash and cash equivalents at year-end increased to ¥12,801 million.

• Comprehensive income increased 87.7% year-over-year to ¥4,188 million.

Outlook and guidance

• FY02/27 sales forecast: ¥65,500 million (+7% YoY); operating profit: ¥5,250 million (+7% YoY); net profit expected to decrease to ¥3,350 million due to absence of prior year one-time gains.

• Basic earnings per share for FY27 is projected at ¥158.32.

• Dividend per share maintained at ¥50; payout ratio policy at 30%.

• Revenue and profit growth planned across all categories, absorbing increased investment costs.